TMPRSS4 is a novel type II transmembrane serine protease that is highly expressed on the cell surface in pancreatic, thyroid and other cancer tissues, although its oncogenic significance and molecular mechanisms are unknown. Previously, we have shown that TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition (EMT). In this study, we explored the molecular basis underlying TMPRSS4-mediated effects. We show that multiple downstream signaling pathways, including focal adhesion kinase (FAK), extracellular signal-regulated kinase (ERK), Akt, Src and Rac1, are activated by TMPRSS4 expression and that FAK signaling and ERK activation are required for TMPRSS4-induced invasiveness and EMT, including cadherin switch. Inhibition of PI3K or Src reduced invasiveness and actin rearrangement mediated by TMPRSS4 without restoring E-cadherin expression. Downregulation of E-cadherin was required for TMPRSS4-mediated effects but was not sufficient to induce EMT and invasion. TMPRSS4 induced integrin a5 expression and its signal transduction, leading to invasiveness and EMT accompanied by downregulation of E-cadherin. Functional blocking confirmed that integrin a5b1 is a critical signaling molecule that is sufficient to induce TMPRSS4-mediated effects. Immunohistochemical analysis showed that TMPRSS4 expression was significantly higher in human colorectal cancer tissues from advanced stages than in that of early stage. Furthermore, upregulation of TMPRSS4 was correlated with enhanced integrin a5 expression. These observations implicate integrin a5 upregulation as a molecular mechanism by which TMPRSS4 induces invasion and contributes to cancer progression.
TMPRSS4 is a novel type II transmembrane serine protease that is highly expressed on the cell surface in pancreatic, thyroid and other cancer tissues, although its oncogenic significance and molecular mechanisms are unknown. Previously, we have shown that TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition (EMT). In this study, we explored the molecular basis underlying TMPRSS4-mediated effects. We show that multiple downstream signaling pathways, including focal adhesion kinase (FAK), extracellular signal-regulated kinase (ERK), Akt, Src and Rac1, are activated by TMPRSS4 expression and that FAK signaling and ERK activation are required for TMPRSS4-induced invasiveness and EMT, including cadherin switch. Inhibition of PI3K or Src reduced invasiveness and actin rearrangement mediated by TMPRSS4 without restoring E-cadherin expression. Downregulation of E-cadherin was required for TMPRSS4-mediated effects but was not sufficient to induce EMT and invasion. TMPRSS4 induced integrin a5 expression and its signal transduction, leading to invasiveness and EMT accompanied by downregulation of E-cadherin. Functional blocking confirmed that integrin a5b1 is a critical signaling molecule that is sufficient to induce TMPRSS4-mediated effects. Immunohistochemical analysis showed that TMPRSS4 expression was significantly higher in human colorectal cancer tissues from advanced stages than in that of early stage. Furthermore, upregulation of TMPRSS4 was correlated with enhanced integrin a5 expression. These observations implicate integrin a5 upregulation as a molecular mechanism by which TMPRSS4 induces invasion and contributes to cancer progression.
Introduction
The epithelial-mesenchymal transition (EMT) is a process implicated in the progression of early-stage non-invasive tumors to invasive malignancies (1) (2) (3) (4) . EMT is also a key event that occurs during normal embryonic development and physiological processes, such as wound healing. EMT is characterized by the loss of apical-basal polarity through the disorganization of cell-cell adhesion, the modulation of cell-matrix interactions, the acquisition of enhanced proteolytic potential for extracellular matrix (ECM) degradation, the rearrangement of the cytoskeleton and the acquisition of an ability to migrate (2) .
During EMT, epithelial cells gradually lose their epithelial structures while concomitantly acquiring the characteristics of mesenchymal cells. In culture, epithelial cells grow as clusters of cells that maintain cell-cell adhesion with neighboring cells, whereas mesenchymal cells maintain a fibroblast-like morphology (1) . Downregulation of E-cadherin is a hallmark of EMT and correlates positively with tumor cell invasion and metastasis. Loss or reduction of E-cadherin suppresses cell-cell interactions and is involved in the induction of certain transcription factors that contribute to cancer metastasis (1, 5) .
Integrins are a family of cell adhesion receptors that activate diverse intracellular signaling molecules and reorganize the actin cytoskeleton to regulate cell adhesion, survival and motility, as well as gene expression (6) (7) (8) (9) (10) . Integrins link the ECM to the intracellular actin cytoskeleton at focal adhesion, where integrins recruit and activate signaling molecules, such as focal adhesion kinase (FAK) and c-Src, and cytoskeletal proteins, such as paxillin and vinculin (7) . In addition, several integrin signaling pathways are involved in EMT events. For example, integrin a2b1 is required for EMT induced by collagen and fibroblast growth factor-1 (1, 11) .
Recently, type II transmembrane serine proteases (TTSPs) have been recognized as a new subfamily of serine proteases with a proteolytic domain, a transmembrane domain, a short cytoplasmic domain and a stem region of variable length that contains modular structural domains (12) (13) (14) . Most TTSPs have been implicated in tumor development and progression, mainly based on their dysregulated expression. TMPRSS4, initially referred to as TMPRSS3, is a TTSP that is highly expressed in pancreatic, thyroid, lung and colorectal cancers (CRCs) (15, 16) . The biological functions of TMPRSS4 and its underlying mechanisms are not, however, well understood. We previously reported that TMPRSS4 is an important mediator of migration, invasion and metastasis in human epithelial cancer cells. In colon cancer cells, overexpression of TMPRSS4 induces loss of E-cadherin and leads to EMT events, including morphological changes and actin reorganization (17) .
In this study, we explored the mechanisms by which TMPRSS4 mediates EMT and invasiveness in tumor cells. TMPRSS4 mediated FAK signaling pathway activation and extracellular signal-regulated kinase (ERK) activation via integrin a5 upregulation, resulting in EMT and invasiveness. Furthermore, TMPRSS4 overexpression in human CRC tissues correlated with enhanced expression of integrin a5.
Materials and methods

Cells
Stable cells (vector-transfected and TMPRSS4-expressing cells) were established from SW480 as described in ref. (17) . Stable cells, parental SW480, NCI-H322 and A549 cells were maintained in RPMI 1640 with 10% fetal bovine serum at 37°C/5% CO 2 .
Patients and samples CRC samples were obtained with informed consent from the Chonnam National University Hwasun Hospital-National Biobank of Korea, and the study was approved by the Institutional Review Board of Chonnam National University Hwasun Hospital. Thirty (stage I, n 5 4; stage II, n 5 11; stage II, n 5 10 and stage IV, n 5 5) and 63 (stage I, n 5 16; stage II, n 5 18; stage III, n 5 19 and stage IV, n 5 10) CRC tissues were obtained for RNA preparation and immunohistochemistry, respectively, from surgically resected specimens.
Transfection with expression vectors and small interfering RNA Cells were transfected for 3 days with the following expression vectors using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) or electroporation (Incyto, Seoul, Korea): pCMV-myc-TMPRSS4 (17) , human E-cadherin complementary DNA (18) , FRNK and Rac1 N17 (kind gifts from D.I. Jeoung, Kangwon National University, Korea) or integrin a5 (19) . SW480T19-or TMPRSS4-expressing NCI-H322 cells were transfected with scrambled small interfering RNA (siRNA) or siRNA against TMPRSS4 (siTMPRSS4) (17) by electroporation.
Abbreviations: CRC, colorectal cancer; ERK, extracellular signal-regulated kinase; EMT, epithelial-mesenchymal transition; FAK, focal adhesion kinase; ECM, extracellular matrix; PCR, polymerase chain reaction; siRNA, small interfering RNA; TTSPs, type II transmembrane serine proteases.
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At 48 h post-transfection, cells were harvested and subjected to an invasion assay, migration assay and immunoblot analysis.
Immunoblot analysis
After appropriate experimental treatments (see below), whole-cell lysates were prepared as described in ref. (20) and conditioned media of cells were precipitated with acetone, which were then analyzed using the following primary antibodies: anti-myc (4A6; Upstate, Lake Placid, NY); anti-E-cadherin (R&D Systems, Minneapolis, MN); anti-b-actin, anti-phospho-FAK (Y397), anti-FAK, anti-c-Src and anti-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA); anti-phospho-ERK1/2, anti-ERK1/2, anti-phospho-FAK (Y925), antiphospho-c-Src (Y416), anti-phospho-Akt and anti-Akt (Cell Signaling, Danvers, MA); anti-E-cadherin, anti-integrin a5 (BD Biosciences, San Jose, CA); anti-integrin a2 and anti-integrin b1 (Chemicon, Temecula, CA); antialpha smooth muscle actin (Sigma, St Louis, MO) and anti-zonula occcludens-1 and anti-cadherin-11 (Invitrogen).
Cells were treated with pharmacological inhibitors, including 25 lM PD098059, 25 lM LY294002, 25 lM wortmannin (Sigma) or 10 or 25 lM PP1 (Biomol, Plymouth Meeting, PA), for 48 h before lysate preparation. For functional blocking, cells were harvested and washed with phosphate-buffered saline and then preincubated for 30 min with normal IgG, anti-integrin a5 (clone IIA1; BD Biosciences) (25 lg/ml) or anti-E-cadherin (DECMA-1; Sigma) (25 or 50 lg/ml). The cell suspension was then replated onto tissue culture dishes and incubated for 10 h or 40 min at 37°C/5% CO 2 prior to cell lysis. In certain experiments, cells were treated with 10 lM cycloheximide (Sigma) for the indicated periods.
Cell death analysis
Cell death was assessed by flow cytometric analysis of propidium iodide uptake. Cells were harvested after the indicated treatments of pharmacological inhibitors and then incubated in 2 lg/ml propidium iodide (Sigma) in phosphate-buffered saline at room temperature for 5 min in the dark. Propidium iodide uptake was measured by flow cytometry analysis on an FACSCalibur (BD, Franklin Lakes, NJ).
Rac1 activity assay
Rac1 activity was determined by pull-down assay as described in ref. (21) . For each assay, 800 lg of total lysate and 20 lg of glutathione S-transferase-p21-activated kinase-1 (amino acids 76-150) bound to glutathione Sepharose beads (Amersham, Buckinghamshire, UK) were used to pull-down active Rac1 (Rac1-GTP). Active Rac1 and input Rac1 were measured by immunoblot analysis using anti-Rac1 (Santa Cruz Biotechnology).
Semiquantitative reverse transcription-polymerase chain reaction Total RNA was isolated using Trizol (Invitrogen). Complementary DNA synthesis and polymerase chain reaction (PCR) were performed as described in ref. (17) to determine TMPRSS4 and GAPDH transcript levels from NCI-H322 cells transfected with siRNA.
Immunocytochemistry
Cells were plated on serum-or fibronectin-coated glass coverslips and incubated for 48 h. Immunofluorescence staining and actin staining were performed as described in ref. (17) . Cells were stained with anti-vinculin fluorescein isothiocyanate conjugate (Sigma) or rhodamine-phalloidin (Molecular Probes, Inc., Eugene, OR). Cells were counterstained with 4,6-diamidino-2-phenylindole (Sigma) for nucleus. Mounted samples were visualized by a fluorescence microscope (IX81; Olympus, Tokyo, Japan).
Morphological analysis
Cells were grown in culture medium on gelatin-coated tissue culture dishes and imaged at Â100 magnification using a phase-contrast microscope (CKX41; Olympus)
Invasion and cell migration assays Invasion and cell migration assays were performed as described in ref. (17) . Cells were plated in serum-free medium on Transwell inserts (Corning, NY) coated with 25 lg of Matrigel (BD Biosciences). Where indicated, cells were plated onto inserts in the presence of pharmacological inhibitors (10 or 25 lM), function-blocking anti-integrin a5 (25 lg/ml), RGD or RGE peptides (300 lg/ml; Peptron, Daejon, Korea) or anti-E-cadherin (DECMA-1) (25 or 50 lg/ml).
Real-time quantitative PCR
Total RNA was isolated using Trizol (Invitrogen) from tissue samples. All RNA samples (1 lg) were reverse transcribed to complementary DNA using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI) according to the manufacturer's protocol. Real-time quantitative PCRs were performed using SYBR Green (SensiMixPlus SYBR; Quantace, London, UK) on a Rotor-Gene 6000 real-time rotary analyzer (Corbett, San Francisco, CA). The 18S rRNA was used as an endogenous control gene for normalization. Gene-specific primer sets were as follows; 5#-CCGATGTGTTCAACTG-GAAG-3# and 5#-GAGAAAGTGAGTGGGAACTG-3# for TMPRSS4 and 5#-CGGCGACGACCCATTCGAAC-3# and 5#-GAATCGAACCCTGATTC-CCCGTC-3# for 18S rRNA. The PCRs was carried out in triplicate on 96-well plates with a final volume of 10 ll per well. After denaturation for 10 min at 95°C, the reaction was continued for 40 cycles at 94°C for 10 sec, 60 or 62°C for 20 sec and 72°C for 20 sec. The C t values for each set of three reactions were averaged for all subsequent calculations. For each sample of CRC, corresponding specimen of normal colonic mucosa from the same patient was used as the control.
Immunohistochemistry
Formalin-fixed and paraffin-embedded tissue sections from patients were deparaffinized, rehydrated, rinsed, stained with anti-TMPRSS4 (1:50 dilution; Protein Tech Group, Chicago, IL), anti-integrin a5 (1:150 dilution; Santa Cruz Biotechnology), anti-E-cadherin (1:100 dilution; Santa Cruz Biotechnology) and anti-cytokeratin (1:100 dilution; Dako North America, Carpinteria, CA) antibodies and analyzed as described in ref. (22) . The staining intensity of TMPRSS4 and integrin a5 appearing as dark brown color was graded according to the following scale: 0, negative; 1þ, weak staining; 2þ, moderate staining and 3þ, strong staining. Immunohistochemical evaluation of E-cadherin was performed in accordance with previously described criteria (23) . The carcinoma cells whose staining intensity was as strong as or stronger than that of non-tumor epithelial cells with membranous accentuation were classified as normal. If the staining intensity was weak or negative or if the staining pattern was not membranous, the cells were regarded as abnormal.
Statistical analysis
Statistical analyses were performed using a Student's t-test, Wilcoxon signedrank test, chi-square test and Pearson test, where P , 0.05 was considered statistically significant.
Results
TMPRSS4 activates FAK and ERK signaling pathways
To examine the effects of TMPRSS4 overexpression on invasion, migration and EMT in colon cancer cells, stable clones were established in SW480 cells as described in ref. (17) . Consistent with our previous findings in TMPRSS4-overexpressing clones (17) , two newly identified TMPRSS4-overexpressing clones (T18 and T19) displayed enhanced invasiveness accompanied by EMT events, including cell spreading, lamellipodia formation and actin rearrangement (data not shown). Furthermore, these TMPRSS4-overexpressing cells displayed reduction of E-cadherin (intact form and soluble fragment; Figure 1A ). On the other hand, these cells exhibited upregulation of integrin a5, whereas the expression of other integrin subunits, including a2 and b1 ( Figure 1A ) and avb3 and avb5 (data not shown), did not significantly change.
To explore the molecular basis underlying TMPRSS4-mediated invasion and EMT, we first investigated the activation of several signaling pathways. Among the molecules we screened, phosphorylation of ERK, FAK at Tyr397 and Tyr925 and Akt was increased in TMPRSS4-overexpressing cells compared with parent SW480-and vectortransfected cells ( Figure 1B ). This effect was seen whether cells were grown under serum-containing condition or on plates coated with fibronectin or collagen type I ( Figure 1B, lower panel) . In addition, phosphorylation of c-Src at Tyr416 was observed when cells were seeded on fibronectin-or collagen I-coated plates ( Figure 1B, lower panel) . Interestingly, integrin a5 expression was also increased upon cell attachment to ECMs in TMPRSS4-overexpressing cells ( Figure 1B) . Activity of the small GTPase Rac1, which induces lamellipodia formation and motility (24) , was also increased in TMPRSS4-overexpressing cells under both serum-containing condition and fibronectin-coated plate condition (Figure 1C) . The TMPRSS4-mediated increase in phosphorylation of FAK, ERK and c-Src was reversed by TMPRSS4 knockdown by transfection with TMPRSS4-specific siRNA compared with scrambled siRNA ( Figure 1D ). Increased integrin a5 expression and decreased E-cadherin levels were also reversed by TMPRSS4 suppression ( Figure 1D) .
To rule out possible clone artifacts, we examined endogenous TMPRSS4-expressing cells for these signaling connections. Using NCI-H322 lung cancer cells transfected with TMPRSS4-specific S. Kim et al. siRNA or scrambled siRNA, we confirmed the positive correlation between TMPRSS4 expression and the observed changes in p-FAK, p-c-Src, p-ERK and integrin a5 ( Figure 1E ). Furthermore, enforced expression of TMPRSS4 in A549 cells with basal level of TMPRSS4 resulted in downregulation of E-cadherin and upregulation of integrin a5 along with enhanced invasion ( Figure 1F and G), confirming that the TMPRSS4-mediated effects are not limited by cell type.
FAK signaling and Rac1 activation are required for TMPRSS4-mediated EMT and invasion
To determine the role of FAK signaling and Rac1 activation in TMPRSS4-mediated invasion and EMT, we transiently transfected SW480T19 cells with FRNK, the naturally occurring dominantnegative inhibitor of FAK, or Rac1 N17, the dominant-negative inhibitor of Rac1. FRNK drastically reduced both T19 cell migration and invasion of a reconstituted basement membrane (Matrigel; Figure 2A ). In contrast, Rac1 N17 significantly reduced T19 cell migration but only moderately reduced T19 cell invasion (Figure 2A) . The inhibitory effect of FRNK on cell invasion was substantially greater than the effect of Rac1 N17, suggesting that FAK may be involved in regulating protein(s) that are specifically required for invasion. Furthermore, cell spreading and the formation of stress fibers, both of which were induced by TMPRSS4 overexpression in T19 cells, were diminished by FRNK or Rac1 N17 expression ( Figure 2B ). FRNK and Rac1 N17 
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significantly decreased phosphorylation of FAK at Tyr397 and Tyr925 but did not substantially affect phosphorylation of ERK or c-Src ( Figure 2C ). Finally, both the cadherin switch (restoration of E-cadherin expression and reduction of cadherin-11 expression) and the downregulation of integrin a5 were also induced by FRNK and Rac1 N17 expression ( Figure 2C ). These results suggest that FAK signaling and Rac1 activation are required for TMPRSS4-mediated invasion, morphological changes and EMT.
Role of different signaling pathways in TMPRSS4-mediated EMT and invasion We next examined the contribution of different TMPRSS4-mediated signaling pathways in inducing EMT and invasion and in downregulating E-cadherin. We treated TMPRSS4-overexpressing cells with the following pharmacological inhibitors for 48 h before analyzing them by immunocytochemistry, invasion assay and immunoblotting: dimethyl sulfoxide (vehicle), PD098059 (a specific MEK inhibitor), LY294002 and wortmanin (specific PI3K inhibitors) and PP1 (a specific c-Src family kinase inhibitor). Inhibition of MEK/ERK, PI3K or c-Src efficiently suppressed stress fiber formation and focal adhesion formation characteristics of EMT but did not substantially affect cell viability ( Figure 3A) . Furthermore, these inhibitors efficiently reduced expression of integrin a5 and cadherin-11, whereas only the inhibition of MEK/ERK reversed the downregulation of E-cadherin ( Figure 3B ). On the other hand, inhibitors of PI3K or c-Src did not substantially inhibit phosphorylation of ERK, whereas phosphorylation of Akt or c-Src was efficiently inhibited, as expected ( Figure 3B ). Inhibition of MEK/ ERK, PI3K or c-Src did, however, significantly reduce cell invasion ( Figure 3C ). These results suggest that E-cadherin restoration is not critical for suppression of EMT and invasion. Taken together, these results suggest that ERK signaling, in addition to FAK signaling (Figure 2 ), is involved in mediating TMPRSS4-induced EMT, cell invasion and downregulation of E-cadherin, whereas PI3K and c-Src are not required for TMPRSS4-mediated downregulation of E-cadherin, although these molecules are involved in TMPRSS4-induced EMT and invasion.
Downregulation of E-cadherin is necessary but not sufficient for TMPRSS4-mediated invasion Because loss and/or reduction of E-cadherin expression correlates positively with tumor cell invasion and is a hallmark of EMT (1,2), we explored whether downregulation of E-cadherin is involved in TMPRSS4-mediated EMT and invasion. We first examined whether ectopic expression of E-cadherin could abolish the EMT and invasiveness mediated by TMPRSS4. When expression of E-cadherin in TMPRSS4-expressing SW480T19 cells was restored to a level similar to that in parental SW480 cells, there was a reduction in cell spreading and lamellipodia formation, as well as a rearrangement of F-actin (from stress fibers to a cortical pattern characteristic of epithelial cells). These morphological changes were accompanied by suppression of integrin a5 and cadherin-11 and a modest induction of zonula occcludens-1, a tight junction protein ( Figure 4A and B) . Reduced cell migration and invasion were also observed following re-expression of E-cadherin ( Figure 4C ). These observations indicate that downregulation of E-cadherin is required for TMPRSS4-mediated invasion, morphological changes and EMT.
On the other hand, blocking endogenous E-cadherin by treating parental SW480 cells with the E-cadherin antibody DECMA-1, which disrupts cell-cell adhesion and induces signaling events including Src-and Shc-dependent ERK activation (25) , failed to induce cell invasion, although it partially enhanced cell spreading in a manner similar to the enhancement in T19 cells and increased phosphorylation of c-Src and ERK ( Figure 4D-F) . Knockdown of E-cadherin by siRNA also failed to induce cell invasion (data not shown). These results indicate that blocking E-cadherin is not sufficient for TMPRSS4-mediated invasion.
TMPRSS4 induces EMT and invasion via upregulation of integrin a5 and its signaling events
To explore further which upstream signaling molecule is responsible for TMPRSS4-mediated signaling pathway activation, EMT and 
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invasion, we focused on the role of integrin a5b1. This was based on the observation that integrin a5, among several integrins we examined, was significantly upregulated by TMPRSS4 ( Figure 1A ). We first examined the TMPRSS4-mediated increase in integrin a5 expression in more detail by treating SW480T19 cells with cycloheximide (a translation inhibitor). We found that integrin a5 expression was associated with increased protein synthesis ( Figure 5A ). We then suppressed integrin a5 function using an antagonizing antibody (clone IIA1). Blocking integrin a5 resulted in moderate restoration of E-cadherin levels and significant inhibition of phosphorylation of FAK at Tyr397 and Tyr925, c-Src at Tyr416, Akt and ERK ( Figure 5B ). Functional blocking of integrin a5 by antibody or RGD peptide inhibitor (6) suppressed invasion of TMPRSS4-expressing T19 cells by 49 and 38%, respectively ( Figure 5C , left panel). Furthermore, blocking integrin a5 also efficiently suppressed endogenous TMPRSS4-expressing NCI-H322 cell invasion ( Figure 5C , right panel). Stress fiber formation and focal adhesion formation were also reduced by treatment with function-blocking antibody and RGD peptide ( Figure 5D ). We next examined the effects of integrin a5 overexpression in SW480 cells displaying a basal level of endogenous TMPRSS4. Enhanced expression of integrin a5 resulted in activation of FAK, c-Src and ERK, as well as EMT induction, including cadherin switch (from E-cadherin to cadherin-11), moderate suppression of zonula occcludens-1 and upregulation of alpha smooth muscle actin ( Figure 5E ). Of note, we failed to detect phosphorylation of Akt as activation of Akt in our system seemed to correlate with the initial period of cell attachment. Cell spreading and lamellipodia formation ( Figure 5F ) and invasion ( Figure 5G) were also induced by integrin a5 overexpression. Taken together, these results suggest that integrin a5 is required for TMPRSS4-mediated EMT and invasion and that integrin a5 is a critical signaling molecule that is sufficient to induce the TMPRSS4-mediated effects.
Expression of TMPRSS4 correlates with those of integrin a5 and E-cadherin and also stage progression in human CRC To determine whether TMPRSS4 is upregulated in human carcinomas, we evaluated TMPRSS4 expression in 30 CRC patients by realtime quantitative PCR. TMPRSS4 messenger RNA levels were higher in CRC tissues than in adjacent normal mucosa (P 5 0.001; Figure 6A) . Next, the expression of TMPRSS4, integrin a5 and E-cadherin were After 72 h, cells were lysed for immunoblotting (E) or photographed using a phase-contrast microscope (F). Arrows indicate representative lamellipodia formation and membrane ruffling. Cells were subjected to invasion assays (G); Scale bars: 50 lm (D and F). All determinations were performed in triplicate in three independent experiments. Values in graphs (C and G) represent mean ± SD; Ã P , 0.05.
immunohistochemically analyzed in serially sectioned 63 human CRC tissues from stages I, II, III to IV CRC patients ( Figure  6B-D) . Increased TMPRSS4 expression correlates with CRC stage progression; moderate to strong TMPRSS4 staining was recorded in 6.3, 33.3, 52.6 and 50.0% of the biopsies in stages I, II, III and IV, respectively ( Figure 6B ). Of note, significant difference for TMPRSS4 staining pattern was observed between early (stage I) and metastatic advanced (stages III-IV) CRCs (P 5 0.003 and P 5 0.01, respectively; Figure 6B ), whereas difference between early (stage I) and non-metastatic advanced (stage II) cancer showed marginal statistical significance at the level of P 5 0.051. These observations suggest that TMPRSS4 might play a role in the progression of non-invasive tumors to invasive malignancies. Furthermore, statistical analysis showed a positive correlation between TMPRSS4 and integrin a5 expression (P 5 0.027; Figure 6C and D), as well as an inverse correlation between TMPRSS4 and E-cadherin expression (P 5 0.001; Figure 6C and D).
Discussion TMPRSS4, a novel TTSP, is highly expressed in pancreatic, thyroid and other cancers, although its oncogenic significance and molecular mechanism remain unknown. We recently reported that TMPRSS4 induces invasion, migration and metastasis of cancer cells by facilitating EMT events (17) . In the current study, we mechanistically explored how TMPRSS4 mediates EMT and invasion. TMPRSS4 affected multiple downstream signaling pathways, including FAK, Src, Rac1, Akt and ERK. More importantly, we identified integrin a5 upregulation as a molecular mechanism by which TMPRSS4 induces signaling transduction, EMT and invasion. In addition, we also demonstrated that TMPRSS4 is upregulated in CRC tissues compared with adjacent normal tissues and increased TMPRSS4 expression correlates with CRC stage progression, implying that TMPRSS4 might be involved in EMT of CRC. Furthermore, upregulation of TMPRSS4 is positively correlated with an induction of integrin a5 Immunostaining was performed as described in Materials and Methods. All cancer cells were stained with anti-cytokeratin (first row). TMPRSS4 and integrin a5 were stained in membranous portion of cancer cells (second and third rows). Note that stromal cells were stained with anti-integrin a5 (third row). Stage I colon cancer sample (left column) shows weak TMPRSS4, negative integrin a5 and intact E-cadherin staining. Stage IV colon cancer sample (right column) contrarily shows strong TMPRSS4, positive integrin a5 and abnormal E-cadherin staining. Magnification Â252; scale bars: 100 lm.
S. Kim et al. expression, implicating integrin a5 as a contributor to cancer progression. It is intriguing that FAK and ERK seemed to be the main signaling molecules involved in separate pathways in TMPRSS4-mediated invasion and EMT, including cadherin switch. Similarly, it has been reported that Ras and Src provide separate regulatory mechanisms for epithelial cell scattering (26) . TMPRSS4 not only modulates cell-cell adhesion, cell-matrix adhesion and migration (17) but also affects the activation of FAK, Rac1 and ERK, which are major downstream effectors of integrins, presumably via regulation of integrin expression and/or cooperation with integrins. We found that TMPRSS4 potently upregulates integrin a5 expression, although we observed partial direct binding of TMPRSS4 and integrin a5 (a5b1) under certain coimmunoprecipitation conditions in human embryonic kidney cells (S.Kim, unpublished data). In contrast, endoproteolytic processing of integrin pro-a subunits (27) was not involved in the TMPRSS4-mediated effects (data not shown), although the TMPRSS4 extracellular domain displayed proteolytic activity toward the standard peptide substrate for trypsin (GlnAla-Arg) (17) . Therefore, it is probable that TMPRSS4 regulates integrin a5 induction and thus regulates its signaling transduction activity. To our knowledge, this study showed for the first time that a TTSP family member can regulate specific integrin expression and its subsequent signaling transduction, leading to EMT and invasion. It is well established that proteases contribute to the degradation of the basement membrane and ECM. Beyond that, proteases may be involved in most stages of the development and progression of cancer through both the direct proteolytic activity and the regulation of cellular signaling and functions (28) (29) (30) . It is worth exploring by which mechanism TMPRSS4 can modulate integrin a5 expression/ signaling. Previously, we showed that TMPRSS4 induces invasion in a manner that is only partially dependent on matrix metalloproteinases but mainly dependent on serine proteolytic activity (17) . We also observed that catalytically inactive mutants of the TMPRSS4 serine protease domain did not substantially enhance invasiveness (S.Kim, unpublished data). In addition, TMPRSS4 is able to activate 1918 influenza virus hemagglutinin by cleavage, suggesting that the proteolytic function of TMPRSS4 is carried out at the cell surface (31) . Therefore, it might be possible that a substrate(s) such as a precursor of a growth factor or of another protease, which is produced by the cancer cell itself and/or the tumor microenvironment, could be cleaved by TMPRSS4, which would in turn induce the activation of a specific transcription factor and expression of a subsequently specific integrin. It is worth exploring by which mechanism TMPRSS4 can modulate integrin a5 expression and which precursor substrates TMPRSS4 can cleave.
Tumor cell invasiveness correlates with changes in integrin expression, and integrin a5b1 is implicated in EMT (32) . Integrin a5b1 is also more highly expressed in highly invasive colon cancer cell lines than in poorly invasive ones (33) . In contrast, integrin a5b1 expression mediates HER-2 downregulation in colon cancer cells, suggesting tumor suppressor-like activity of integrin a5b1 (34) . The role of integrin a5b1 in colorectal carcinoma is thus unclear. In this study, we demonstrated that TMPRSS4-induced integrin a5 promotes invasion and is positively correlated with colon cancer progression. This finding is consistent with recent reports, showing that integrin a5b1 is implicated in colon cancer metastasis (35) and in EGF-induced EMT in cervical cancer (36) .
We observed that E-cadherin levels were substantially reduced in stable TMPRSS4-overexpressing cells, a phenomenon that is unlikely to be attributed to cleavage by proteases such as matrix metalloproteinases ( Figure 1A) or by promoter methylation (data not shown). In an attempt to determine the transcriptional repressor responsible for E-cadherin downregulation in TMPRSS4-expressing cells, we investigated the potential role of SIP1/ZEB2 (17) . Interestingly, knockdown of SIP1/ZEB2 did not reverse E-cadherin downregulation in TMPRSS4-overexpressing cells, but overexpression of SIP1/ZEB did suppress E-cadherin expression (data not shown). This result indicates that SIP1/ZEB2 is not critically involved in E-cadherin downregulation in TMPRSS4-mediated EMT and invasion and that other transcriptional regulators are probably to be involved.
Loss of E-cadherin-mediated cell-cell adhesion is involved in tumor progression (37) . Reconstitution of E-cadherin results in a tumor cell reversion from an invasive mesenchymal phenotype to a benign epithelial phenotype (37, 38) . On the other hand, suppression of high endogenous E-cadherin expression renders non-invasive cells partially invasive (38) , whereas E-cadherin loss can promote metastasis via multiple downstream transcriptional pathways (5) . In this study, we observed that downregulation of E-cadherin is required for TMPRSS4-mediated invasion and EMT but is not sufficient for induction of these phenotypes. That is, downregulation of E-cadherin is not the sole contributor to TMPRSS4-mediated phenotypes. In the future, it will be important to elucidate whether the induction of specific mesenchymal markers (e.g., integrin a5) (39) , in addition to the downregulation of tumor suppressors such as E-cadherin, is required for full invasiveness during progression of colon cancer. 
